Bristol Myers Squibb Drug Patent Portfolio

Bristol Myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb News

PFE or BMY: Which Major Cancer Treatment Company Is the Superior Choice at This Time? - TradingView

16 Mar, 2026

Could Bristol Myers' Extensive Pipeline Be Crucial for Future Expansion? - TradingView

12 Mar, 2026

Reasons Behind Bristol Myers Squibb's Stock Surge in February - The Globe and Mail

09 Mar, 2026

BMY Sees 11.4% Increase Over the Past Month: Is It Time to Buy, Sell, or Hold? - The Globe and Mail

03 Mar, 2026

See More